Solabia-Algatech launches algae beta-glucan ingredient for immune health
The ingredient is a whole-algae source of Euglena gracilis.
Solabia-Algatech Nutrition (Kibbutz Ketura, Israel) has launched an algae-sourced beta-glucan ingredient for immune support called BioGlena. The ingredient is a whole-algae source of Euglena gracilis. The company says the beta-1,3-glucans in E. gracilis are “specifically recognized by immune-cell receptors.”
A proprietary fermentation process ensures BioGlena has a high beta-glucan content of greater than 55%, the company says. Solabia-Algatech says the beta-glucan content of Euglena gracilis can vary, depending on growth conditions and medium composition, but that its multi-patented process ensures a consistent beta-glucan concentration. Processing is done without solvents or additives. The ingredient also contains protein and essential vitamins, minerals, and fatty acids.
“Beta-glucans are naturally occurring polysaccharides known for their positive effect on the immune system, with more than 12,000 scientific papers published in the past few decades,” said Doron Safrai, CEO of Solabia-Algatech Nutrition, in a press release. “While grains, yeast, and certain fungi are traditional sources of beta-glucans, researchers and formulators are increasingly recognizing E. gracilis as a significant high-value source.”
“In E. gracilis, the beta-glucan molecules are concentrated inside free-floating granules inside the algae, as opposed to fungi and yeast sources in which the powerful polysaccharides are bound to the cell wall,” said Omer Grundman, PhD, vice president, R&D, for Solabia-Algatech Nutrition. “This eliminates the need for harsh extraction procedures to isolate the beta-glucans. BioGlena contains the whole algae and no cell wall, allowing the beta-glucans to be naturally released in the gastrointestinal tract during digestion. This is a major advantage of E. gracilis over other beta-glucan sources, opening the door for BioGlena to become a leading immune-support ingredient.”
BioGlena is Generally Recognized as Safe (GRAS) and is supplied in a powder that is suitable for dispersible formulas. It can be used in dietary supplement pills, tablets, and gummies, as well as food and beverage products.
Kratom sees impressive sales growth despite its regulatory status and stigma
March 12th 2025Despite its controversy, kratom is a top-selling ingredient that consumers see value in. That said, brands need to work hard to demonstrate safety and quality of kratom products in the absence of legal regulatory status. Will kratom be able to overcome its stigma for even more growth and consumer acceptance?
DOJ asks Utah court to dismiss FTC lawsuit against Xlear Inc.
March 11th 2025On March 10, the DOJ and the defendant filed a stipulation to dismiss with prejudice the lawsuit in which each party agrees “to be responsible for its own costs and fees and agrees that no party shall be responsible to any other party for any fines, costs, fees, or penalties arising from this case.”
HHS announces efforts to eliminate independent conclusion of GRAS
Published: March 11th 2025 | Updated: March 11th 2025U.S. Department of Health and Human Services (HHS) Secretary, Robert F. Kennedy Jr., is directing the acting U.S. Food and Drug Administration’s (FDA) acting commissioner to explore rulemaking that would eliminate the independent conclusion of GRAS provision.
